Best Life Sciences Companies in Orlando, United States
The 62 best Life Sciences companies in Orlando, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: LensAR.
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Orlando
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | LensAR Laser Technology with AR feature for cataract surgery 67Innovation top 13%Patents top 14%Funding top 27%Fin. health top 27% All 10 signals ▾Innovationtop 13% Patentstop 14% Fundingtop 27% Fin. healthtop 27% Techtop 37% Moattop 44% Markettop 48% Newsbottom 44% Globalbottom 38% Growthbottom 29% Innovation: 377 patents (top 2% of patent-holders) · 175 filings since 2022 vs 101 in 2017-21 Patents: 377 patents matched (strict assignee match) · 175 filings since 2022 vs 101 in 2017-21 rank vs industry peers · Fliar Intelligence Index 67/100 | $99M | 37 mo ago | 67 67 → 164 (+145%) | 2004 | — | DrupalApple iCloud MailMicrosoft 365+29 | 377 patents Ophthalmic laser surgery devices and patient interface systems for eye procedures | 1 partnership |
| 2 | Obvio Health Provider of clinical trials design and recruitment platform 48Funding top 27%Product top 34%Moat top 39%Tech top 44% All 11 signals ▾Fundingtop 27% Producttop 34% Moattop 39% Techtop 44% Growthtop 45% Partnerstop 45% Markettop 50% Talentbottom 49% Globalbottom 39% Newsbottom 18% Customersbottom 17% Funding: Raised $66.0M across 4 rounds · 4 rounds over 8 yrs (0.5/yr) Product: 18 published apps (10.9k installs) · Company stage: Series B rank vs industry peers · Fliar Intelligence Index 48/100 | $66M | 23 mo ago | 168 | 2015 | Ivan Jarry Chief Executive Officer | WebflowSentryApple iCloud Mail+23 | — | 1 launch |
| 3 | Hesperos Developer of organ-on-a-chip solutions for preclinical testing | $29M | 13 mo ago | 15 | 2015 | James Hickman Co-Founder | — | 11 patents Patents concentrated in transport & manufacturing processes | — |
| 4 | CORD:USE Cord Blood Provider of umbilical cord blood stem cell storage services | $27M | 111 mo ago | — | 2004 | Edward Guindi President & CEO | — | — | — |
| 5 | Fibronostics Non-invasive algorithm-based diagnostics | $14M | 48 mo ago | 17 | 2015 | — | WordPressMySQLPHP+24 | — | 2 launchs |
| 6 | AOI Medical Orthopaedic medical devices for spine and trauma | $6M | 173 mo ago | 1 | 2004 | Julian M. Mackenzie Chief Executive Officer | — | — | — |
| 7 | Mazor Robotics Medical technology company specializing in innovative healthcare solutions globally | $6M | 105 mo ago | 88 | 2001 | Moshe Shoham Co-Founder | — | — | — |
| 8 | InteGen Provider of cytogenetics, DNA FISH probes for research application | $5M | 92 mo ago | 4 | 2011 | Ramesh Babu Founder & CEO | — | — | — |
| 9 | Medite Developer of products for histology and cytology | $3M | 92 mo ago | 71 | 1978 | — | Cart FunctionalityShopifyAMP+16 | — | — |
| 10 | B4 Manufacturers of vitamin supplement beverages | $2M | 71 mo ago | 2 | 2015 | — | — | — | — |
| 11 | MicroGen Diagnostics Provider of sequencing and molecular diagnostic services | $2M | 110 mo ago | 142 | 2011 | Randall Wolcott Founder | Cart FunctionalityWooCommerceWordPress+32 | — | — |
| 12 | AVRA Medical Robotics Developer of AI-based surgical robotics systems for healthcare | $2M | 104 mo ago | 13 | — | Barry Cohen Founder | — | — | — |
| 13 | HyperFlex Developer of minimally invasive bunion correction system for mild-to-moderate hallux valgus | $1M | 12 mo ago | — | 2019 | Bob Peterhans Chief Executive Officer | — | — | — |
| 14 | Aviana Molecular Technologies Point-of-care diagnostics company revolutionizing healthcare testing with mobile biosensor technology | $1M | 111 mo ago | 9 | 2009 | Vanaja Ragavan Chief Executive Officer and Chairman | — | 81 patents Surface acoustic wave biosensor platforms for multiplexed point-of-care diagnostics. | — |
| 15 | AeroCare Holdings Provider of medical devices for obstructive respiratory diseases and sleep apnea | $1M | 80 mo ago | 2,731 | 2002 | Steve Griggs CEO | — | — | — |
| 16 | 1nHealth Provides subject recruitment for clinical research | $653K | 82 mo ago | 26 | 2019 | Dan Brenner Founder & CEO | WordPressApple iCloud MailMicrosoft 365+27 | — | 1 award |
| 17 | Micro-gRx Developer of biological platforms for medical treatments and therapies on Earth | $382K | 20 mo ago | — | 2014 | Siobhan Malany Founder | — | — | — |
| 18 | Diverse Biotech Developer of therapeutics for treating cancer | $338K | 81 mo ago | 6 | 2017 | — | — | 41 patents Cannabinoid‑beta‑lactam conjugate therapeutics for antiviral and anti‑cancer applications | — |
| 19 | Nutriband Transdermal drug delivery technologies improving patient safety and deterring drug abuse | $215K | 97 mo ago | 15 15 → 10 (-33%) | 2012 | — | Wix eCommerceWixSentry+15 | 7 patents Deterrent transdermal drug delivery patches that prevent abuse and misuse | — |
| 20 | Standard Dental Labs Manufacturer of dental products, including implants, crowns, bridges, and dentures | $118K | 8 mo ago | — | 1998 | James Brooks Chief Executive Officer | — | — | — |
| 21 | GeneLink BioSciences Genome-based nutritional supplements | $105K | 158 mo ago | 15 | 1994 | Robert Ricciardi Founder | — | — | — |
Top 12 Life Sciences companies in Orlando
#1
Funding Raised · Orlando, Florida · founded 2015 · 15 employees$29.1Mraised▾
Developer of organ-on-a-chip solutions for preclinical testing. The company has a heart-liver two organ model, heart-liver- skeletal muscle-neuron organ model, neuromuscular junction organ model, and heart-liver-cancer two organ model. These are a pumpless body-on-a-chip platform that uses a serum-free cellular medium, integrated computer modeling software, and physiological monitoring solutions.
- Apr 2025Grant (prize money)$2M
- Aug 2021Grant (prize money)$2M
- Sep 2020Grant (prize money)$1.8M
- Sep 2018Grant (prize money)$1.7M
#2
Series B · Orlando, Florida · founded 2015 · 168 employees$66Mraised▾
Provider of clinical trials design and recruitment platform. It offers solutions for decentralized clinical trials, recruitment & screening, remote patient monitoring, and patient engagement. It also, assist with collecting real world data in clinical trials, that link to various health devices.
- Jul 2024Series B—
- Nov 2023Series B$15M
- Jul 2021Series B$31M
- May 2020Series B$17M
#3
Seed · Orlando, Florida · founded 2019$1.4Mraised▾
Developer of minimally invasive bunion correction system for mild-to-moderate hallux valgus. The company provides a non-osteotomy solution that gently realigns and stabilizes metatarsal bones, preserving natural foot motion without cutting or drilling bone. The system offers a streamlined surgical workflow with disposable instrumentation, integrating into existing operating room procedures. It allows for earlier treatment of bunions, potentially reducing complications and supporting quicker patient recovery.
- Jun 2025Seed$1.4M
#4
Acquired · Orlando, Florida · founded 2004 · 67 employees$99Mraised▾
LensAR, is a leader in the development and commercialization of next-generation laser and advanced 3D imaging technology for refractive cataract surgery. The company product LensAR Laser System has been cleared by the FDA for anterior capsulotomy and lens fragmentation.
- May 2023Post IPO$20M
- Jan 2015Series D$16M
- Jan 2014Series C$10M
- Oct 2013Conventional Debt$60M
#5
Seed · Orlando, Florida · founded 1998$117.5Kraised▾
Manufacturer of dental products, including implants, crowns, bridges, and dentures. The company provides dental clinics with a range of restorative options. It focuses on collaborating with dental professionals to meet specific requirements. The manufacturer aims to deliver consistent and accurate results for patient care.
- Sep 2025Seed$117.5K
#6
Funding Raised · Orlando, Florida · founded 2014$382.1Kraised▾
Developer of biological platforms for medical treatments and therapies on Earth. The company integrates biology platforms with payload hardware to solve issues related to spaceflight. It focuses on understanding human biology in extraterrestrial environments. The company develops new therapies to help fight diseases and biological ailments.
- Oct 2024Grant (prize money)$382.1K
#7
Series A · Orlando, Florida · founded 2015 · 17 employees$14.5Mraised▾
Non-invasive algorithm-based diagnostics. The company uses machine learning to target specific physiological and pathological processes, in order to assess subclinical biomarker profiles in plasma for diagnosis and prognosis of disease pathologies. Applications under investigation include cardiometabolic diseases, idiopathic pulmonary fibrosis, and chronic renal diseases.
- Jun 2022Series A$6.5M
- Aug 2020Series A$8M
#8
Acquired · Orlando, Florida · founded 2004$27Mraised▾
Provider of umbilical cord blood stem cell storage services. The company engages in processing and storing a newborn’s umbilical cord blood for the possible future use by that individual or their family members; and Public Cord Blood Bank, which collects processes, and stores donated cord blood to be made publically available for patients in need of a transplant.
- Mar 2017Series A$250K
- Mar 2016Series A$875K
- Jul 2015Series A$3M
- Jul 2014Series A$15.3M
#9
Acquired · Orlando, Florida · founded 2001 · 88 employees$6.3Mraised▾
Medical technology company specializing in innovative healthcare solutions globally. They are dedicated to advancing health through a wide array of medical devices and therapies. Their offerings span across various specialities including neurological, cardiac, spinal, surgical, and diabetes-related products. They cater to both healthcare professionals and patients, providing resources, education, and support services. They focus on improving patient outcomes through cutting-edge technology and comprehensive care solutions. They operate globally, serving diverse markets with a commitment to quality, ethics, and innovation in the medical field. They also focus on digital ordering and services, reimbursement, and patient services.
- Aug 2017Post IPO$40M
- Aug 2016Post IPO$20M
- May 2016Post IPO$11.9M
- Feb 2011PE$6.3M
#10
Series A · Orlando, Florida · founded 2011 · 4 employees$4.6Mraised▾
InteGen LLC is a biotechnology company dedicated to providing reagents/tools for the cytogenetics community. It specifically develops and markets DNA FISH probes that can be used in the individual chromosome profiling in interphase cells for hematologic malignancies and genetic disorders including miscarriages. Additionally, the company also markets other products for cytogenetic studies.
- Oct 2018Series A$4.2M
- Jan 2011Seed$450K
#11
Series A · Orlando, Florida · founded 2004 · 1 employees$6.3Mraised▾
Orthopaedic medical devices for spine and trauma
#12
Seed · Orlando, Florida · founded 2015 · 2 employees$2.1Mraised▾
Sunshine Supplements manufactures and markets vitamin supplement beverages. Its product offering includes vitamin supplements in various flavors such as berry, grape, and orange in various packs. Its drinks consist of B Vitamins, glutathione, and milk thistle.
- Jul 2020Seed$951.4K
- Feb 2018Seed$400K
- Oct 2017Seed$762.5K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in the United States
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 6,260 United States-affiliated papers.
- Harvard University209
- Cornell University177
- University of Tennessee at Chattanooga140
- Howard Hughes Medical Institute126
- Johns Hopkins University121
- Gene33→164
- Transcription (linguistics)11→79
- Antibody11→62
- Genome6→56
- Mutation7→56
- Gene8→110
- Cell culture3→62
- Gene expression3→62
- Fermentation2→54
- Downregulation and upregulation1→50
- Agriculture19→58
- Antibiotic resistance15→45
- Public health4→31
- Gene6→30
- Production (economics)5→29
Where biotechnology is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in the United States
United States biotechnology patent filing is accelerating — 457,918 filings from 8,000 assignees (2016–2025), led by Genentech, UNIV California, Regeneron Pharma; annual filings 36884→44446.
- Genentech18078
- UNIV California17948
- Regeneron Pharma16082
- Amgen10495
- Monsanto Technology9742
- UNIV Pennsylvania8521
- Harvard College7460
- UNIV Texas7378
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.